JPS6117065A - Measuring reagent for human chorionic gonadotropin - Google Patents
Measuring reagent for human chorionic gonadotropinInfo
- Publication number
- JPS6117065A JPS6117065A JP13709284A JP13709284A JPS6117065A JP S6117065 A JPS6117065 A JP S6117065A JP 13709284 A JP13709284 A JP 13709284A JP 13709284 A JP13709284 A JP 13709284A JP S6117065 A JPS6117065 A JP S6117065A
- Authority
- JP
- Japan
- Prior art keywords
- highly specific
- hog
- monoclonal antibody
- hcg
- chorionic gonadotropin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Reproductive Health (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
【発明の詳細な説明】
産業上の利用分野
本発明は、特異性の高いヒト絨毛性ゴナドトロピン(以
下HOGと略す)の免疫化学的測定に用いる試薬の発明
である。DETAILED DESCRIPTION OF THE INVENTION Field of Industrial Application The present invention is an invention of a reagent used for highly specific immunochemical measurement of human chorionic gonadotropin (hereinafter abbreviated as HOG).
HOGはヒト胎盤の絨毛組織より分泌される蛋白ホルモ
ンであり、尿中のHOGの検出は妊娠の初期診断に利用
されている。HOG is a protein hormone secreted by the villous tissue of the human placenta, and detection of HOG in urine is used for early diagnosis of pregnancy.
近年になって悪性腫瘍の中には、HOGを多く産生ずる
ものがかなりあることが明らかになっており、体液中の
HOGの測定は悪性腫瘍の診断と経過観察にも利用され
ている。In recent years, it has become clear that some malignant tumors produce a large amount of HOG, and measurement of HOG in body fluids is also used for diagnosis and follow-up of malignant tumors.
従来の技術
HOGめ測定法としては、放射免疫測定法(aadio
−imnunoassay以下RIAと略す)、酵素免
疫測定法(Bnlyme+rrmunoassay
以下EIAと略す〕、ラテックス法等の免疫化学的方法
が多く用いられている。Conventional HOG measurement methods include radioimmunoassay (aadio
-immunoassay (hereinafter abbreviated as RIA), enzyme immunoassay (Bnlyme+rrmunoassay)
Immunochemical methods such as the latex method (hereinafter abbreviated as EIA) and the latex method are often used.
発明が解決しようとする問題点
HOGは、α、βのサブユニットからなる分子量37、
000の糖蛋白ホルモンである。そのαサブユニットは
、黄体形成ホルモン(以下LHと略す〕、卵胞刺激ホル
モン(以下FSHと略す)、甲状腺刺激ホルモン(以下
TSHと略す)等のαサブユニットとはg同様のアミノ
酸配列を有している。一方HOGのβサブユニットホ、
FSHやTSHのβサブユニットとはアミノ酸配列を異
にするが、LHのβサブユニットとは類似している。詳
しくは、HOGのβサブユニットの方がカルボキシル基
末端で30個長いペプチド鎖を有するが、アミ7基末端
から115個のアミノ酸配列中92個はLHのβサブユ
ニットと共通である。Problems to be solved by the invention HOG has a molecular weight of 37, consisting of α and β subunits.
000 glycoprotein hormones. The α subunit has an amino acid sequence similar to that of α subunits such as luteinizing hormone (hereinafter abbreviated as LH), follicle stimulating hormone (hereinafter abbreviated as FSH), and thyroid stimulating hormone (hereinafter abbreviated as TSH). On the other hand, the β subunit of HOG,
It has a different amino acid sequence from the β subunits of FSH and TSH, but is similar to the β subunit of LH. Specifically, the β subunit of HOG has a peptide chain that is 30 longer at the carboxyl group end, but 92 of the 115 amino acid sequences from the ami7 end are common to the LH β subunit.
以上の理由により、HOGの免疫化学的測定法ではLH
の交叉反応が大きな問題となる。For the above reasons, in the immunochemical assay of HOG, LH
Cross-reactions are a major problem.
通常の免疫操作で得られたポリクローナル抗体はLHと
ある程度交叉反応を示すことが知られており、このよう
な抗体を利用した免疫化学的測定法ではHOGとLHの
判別のつかない検体がみられ特異性の高い測定法ではな
かった。It is known that polyclonal antibodies obtained through normal immunoassays exhibit some degree of cross-reactivity with LH, and immunochemical assays using such antibodies have resulted in samples in which it is difficult to distinguish between HOG and LH. It was not a highly specific measurement method.
HOGのモノクローナル抗体に関しても数多くの報告が
なされている。wada et a+、 (01in、
0hen。Many reports have also been made regarding HOG monoclonal antibodies. wada et a+, (01in,
0hen.
28巻 1862頁(19B2)月ま、伏定化したHO
Gのαサブユニットに対するモノクローナル抗体と酵素
標識したβサブユニットに対するモノクローナル抗体を
用いるHOGのサンドイツチEIA法を報告している。Volume 28, page 1862 (19B2) Tsukima, HO that has been suppressed
reported the Sand-Germany EIA method of HOG using a monoclonal antibody against the α subunit of G and an enzyme-labeled monoclonal antibody against the β subunit.
しかし、彼らの報告によると、LHとの交叉反応は8゜
3%と比較的高(LHの高値を示す検体に対しては問題
があるものと思われる。However, according to their report, the cross-reaction with LH is relatively high at 8.3% (there seems to be a problem with samples showing high levels of LH).
問題点を解決するための手段
本発明者は上記の事情に鑑み、鋭意研究を重ねた結果、
2種のモノクローナル抗体を用いるHOGのサンドイン
チ法において、HOGの分子構造全体に特異性の高いモ
ノクローナル抗体とHOGのβサブユニットに特異性の
高いモノクローナル抗体を使用することにより、LH,
、FSH等とほとんど交叉反応を示さないHOGに極め
て特異性の高い測定方法を編み出し本発明を完成した。Means for Solving the Problems In view of the above circumstances, the inventor has conducted intensive research and has found that
In the HOG sandwich method using two types of monoclonal antibodies, LH,
The present invention has been completed by devising a highly specific measurement method for HOG that shows almost no cross-reactivity with , FSH, etc.
本発明の試薬が使用される測定方法を、さらに具体的に
述べる。The measurement method using the reagent of the present invention will be described in more detail.
本発明において使用されるモノクローナル抗体は、細胞
融合の技術(Nat’ure 256巻 495頁(1
975年))を利用して作製される。その作製法を以下
に簡単に概説する。The monoclonal antibodies used in the present invention can be obtained using cell fusion technology (Natural Vol. 256, p. 495 (1).
975)). The manufacturing method will be briefly outlined below.
まずHOGを抗原としてマウスに免疫し、得られた牌細
胞とマウス由来の骨髄腫細胞とを融合後、クローニング
してHOGに対する抗体を産生している細胞を選び出す
。得られた細胞が産生ずるモノクローナル抗体は、HO
G分子のある特定部位に対応する特異的な抗体である。First, mice are immunized with HOG as an antigen, and the resulting tile cells are fused with mouse-derived myeloma cells, followed by cloning to select cells that produce antibodies against HOG. The monoclonal antibodies produced by the obtained cells are HO
It is a specific antibody that corresponds to a specific part of the G molecule.
次にこのようにして得られたモノクローナル抗体の特異
性をRIAにより検討し、LHとの交叉反応の低いHO
Gの分子構造全体に特異性の高いモノクローナル抗体と
、HOGのβサブユニットに特異性の高いモノクローナ
ル抗体を選択する。尚、HOGのβサブユニットに特異
性の高いモノクローナル抗体は、マウスにHOGのβサ
ブユニットを免疫し、細胞融合後クローニングすること
によっても得ることができる。Next, the specificity of the monoclonal antibody obtained in this way was examined by RIA, and HO, which has low cross-reactivity with LH,
A monoclonal antibody that is highly specific for the entire molecular structure of G and a monoclonal antibody that is highly specific for the β subunit of HOG are selected. Furthermore, a monoclonal antibody highly specific to the HOG β subunit can also be obtained by immunizing a mouse with the HOG β subunit and cloning the antibody after cell fusion.
これらのモノクローナル抗体は、例えば001〜1岬/
mlの水溶液として、あるいは不溶性担体に固定化し、
又、標識抗体として本発明の測定用試薬とすることがで
きる。These monoclonal antibodies are, for example, 001-1 Misaki/
ml aqueous solution or immobilized on an insoluble carrier,
Furthermore, the labeled antibody can be used as the measurement reagent of the present invention.
本発明の試薬によってHOGを測定するには、不溶性の
担体に固定化したある一種のモノクローナル抗体に抗原
となるHQGを反応させた後、別の一種のモノクローナ
ル抗体に放射性物質あるいは酵素等を標識した標識抗体
を反応させる手法いわゆるサンドイツチ法が好適である
。To measure HOG using the reagent of the present invention, one type of monoclonal antibody immobilized on an insoluble carrier is reacted with HQG as an antigen, and then another type of monoclonal antibody is labeled with a radioactive substance or an enzyme. A method of reacting a labeled antibody, the so-called Sandermansch method, is suitable.
固定化に用いる不溶性担体としては、ポリスチレン球、
ガラスピーズ、ラテックス、シリコーン片等が利用され
る。Insoluble carriers used for immobilization include polystyrene spheres,
Glass beads, latex, silicone pieces, etc. are used.
この場合に採用される標識抗体としては、放射性同位元
素(例えば゛工、1311、−など〕や、酵素(例えば
、ペルオキシダーゼ、β−ガラクトシダーゼ、アルカリ
性フォスフェターゼなど〕等をモノクローナル抗体に結
合させることにより製造できる。The labeled antibodies employed in this case include radioactive isotopes (e.g., 1311, -, etc.), enzymes (e.g., peroxidase, β-galactosidase, alkaline phosphetase, etc.), etc. bound to monoclonal antibodies. It can be manufactured by
放射性同位元素と抗体を結合する方法としてはクロラミ
ンT法(Nature 194巻 495頁(L962
年))やラクトパーオキシダーゼ法等があり、酵素と抗
体を結合させる方法としては、過ヨウ素酸法(J、 H
istochem、 Oytochem、 22巻10
84頁(1974年))、混合酸無水物法、カルボジイ
ミド法等がある。As a method for binding radioisotopes and antibodies, the chloramine T method (Nature, Vol. 194, p. 495 (L962
There are methods such as the periodic acid method (J, H
Istochem, Oytochem, Volume 22 10
84 (1974)), mixed acid anhydride method, carbodiimide method, etc.
サンドイツチ法によりHOGを測定する方法を更に具体
的に説明する。A method for measuring HOG using the Sanderch method will be explained in more detail.
まずある一種のモノクローナル抗体(例れば、HOGの
βサブユニットに特異性の高いモノクローナル抗体)を
不溶化しである固相に被測定検体を加えて一定温度で一
定時間反応後、反応液を洗浄除去する。次いで標識され
た別の一種のモノクローナル抗体(例えば、HOGの分
子構造全体に特異性の高いモノクローナル抗体〕を加え
て更に一定時間反応させ、反応液を洗浄除去する。First, a certain type of monoclonal antibody (for example, a monoclonal antibody with high specificity for the β subunit of HOG) is insolubilized, the analyte to be measured is added to the solid phase, and after reaction at a certain temperature for a certain period of time, the reaction solution is washed. Remove. Next, another type of labeled monoclonal antibody (for example, a monoclonal antibody highly specific to the entire molecular structure of HOG) is added, the reaction is further allowed to proceed for a certain period of time, and the reaction solution is washed away.
標識抗体として放射性同位元素を用いた場合は直接反応
物の放射能を測定する。If a radioactive isotope is used as the labeled antibody, directly measure the radioactivity of the reactant.
標識抗体として酵素を用いた場合には、酵素の基質を加
えて酵素反応を行なわさせ酵素活性を測定する。When an enzyme is used as the labeled antibody, a substrate for the enzyme is added to carry out an enzyme reaction, and the enzyme activity is measured.
上記により得られた放射能の量や酵素活性は、被測定検
体中のHOG量に対応して増加するので、あらかじめH
OG濃度既知の標準液で検量線を描いておけば、検体中
のHOG量が測定できるわけである。The amount of radioactivity and enzyme activity obtained above increase in accordance with the amount of HOG in the sample to be measured, so
By drawing a calibration curve using a standard solution with a known OG concentration, the amount of HOG in a sample can be measured.
上述し1こ方法は、いわゆる2ステツプ法であるが1ス
テツプ法でも測定可能である。即ち、不溶化したモノク
ローナル抗体に未知検体と標識抗体を同時に添加し、一
定時間反応させる。反応液を洗浄、除去後、反応物の放
射能あるいは酵素活性を測定することにより検体中のH
OG量を知ることができる。The first method mentioned above is a so-called two-step method, but measurement can also be performed using a one-step method. That is, an unknown specimen and a labeled antibody are simultaneously added to the insolubilized monoclonal antibody and allowed to react for a certain period of time. After washing and removing the reaction solution, H in the sample is determined by measuring the radioactivity or enzyme activity of the reaction product.
You can know the amount of OG.
以下、さらに実施例によって説明するが本発明はこれに
限定されるものではない。The present invention will be further explained below with reference to Examples, but the present invention is not limited thereto.
実施例1 サンドイツチ法によるHOGの測定(1)モ
ノクローナル抗体の作製
HOG150μgを完全フロイントのアジュバントと混
合し、BALB10マウスの腹腔内に投与した。Example 1 Measurement of HOG by Sand-Deutsch method (1) Preparation of monoclonal antibody 150 μg of HOG was mixed with complete Freund's adjuvant and administered intraperitoneally to BALB10 mice.
1=3ケ月後にHOG 50μgを腹腔内に投与し、6
日間にマウスの牌臓を摘出した。牌細胞と骨髄腫細胞(
P3−NSI /1−A74−1 )を5=1の割合で
混合して、ポリエチレングリコール4ooo存在下で細
胞融合を行なった。1 = After 3 months, 50 μg of HOG was administered intraperitoneally, and 6
The spleens of the mice were removed on the following day. Pile cells and myeloma cells (
P3-NSI/1-A74-1) were mixed at a ratio of 5=1, and cell fusion was performed in the presence of polyethylene glycol 4ooo.
ヒポキサンチン・アミノプテリン・チミジン培地で培養
することにより融合細胞を選別し、培養上清のHOG抗
体の量をRIAにより測定した。Fused cells were selected by culturing in a hypoxanthine-aminopterin-thymidine medium, and the amount of HOG antibody in the culture supernatant was measured by RIA.
活性を有する融合細胞は限界希釈法により単一クローン
産生細胞とした後、あらかじめプリスタンを投与したマ
ウスに接種することにより腹水を得た。腹水は50チ飽
和硫安により塩析後、DEAEセルロースカラムにより
I、G分画を精製した。The active fused cells were converted into single clone-producing cells by limiting dilution, and then inoculated into mice that had been previously administered pristane to obtain ascites. Ascites was salted out with 50% saturated ammonium sulfate, and I and G fractions were purified using a DEAE cellulose column.
得うれたモノクローナル抗体の特異性について、HOG
の几IAにより検討した。Regarding the specificity of the obtained monoclonal antibody, HOG
This study was conducted using the 几IA.
HOGの交叉反応を1.00 %とするとある1つのモ
ノクローナル抗体は、LI(と2%、H(3Gのαサブ
ユニット、HOGのβサブユニット、FsHとは1チ以
下の交叉反応しか示さず、HOGの分子構造全体に特異
性の高いモノクローナル抗体であった。If the cross-reactivity with HOG is 1.00%, one monoclonal antibody shows less than 1 cross-reactivity with LI (2%), H (α subunit of 3G, β subunit of HOG, and FsH). , a monoclonal antibody with high specificity for the entire molecular structure of HOG.
別の1つのモノクローナル抗体はHOGの交叉反ト、L
HlFSI(とは1チ以下の交叉反応しか示さず、HO
Gのβサプユニッ)[特異性の高いモノクローナル抗体
であった。Another monoclonal antibody is a crossantibody of HOG, L
HlFSI (shows less than 1 cross reaction with HO
G β-subunit) [It was a highly specific monoclonal antibody.
(2)モノクローナル抗体を不溶化したポリスチレン球
の作製
(1)で得たHOGのβサブユニットに特異性の高いモ
ノクローナル抗体を01■/mlとなるように001M
リン酸緩衡液(pH7,3つ、09チ塩化ナトリウム液
(PBS)に溶解した溶液にポリスチレン球(64朋φ
〕を浸せきし、30℃で18時間静置した。ポリスチレ
ン球を液より分離し洗浄後、01%牛血清アルブミンを
含むPBS中に4℃で保存し使用に供した。(2) Preparation of polystyrene spheres with insolubilized monoclonal antibodies Add the monoclonal antibody with high specificity to the β subunit of HOG obtained in (1) to a concentration of 0.01M/ml.
Polystyrene spheres (64mm φ
] and left at 30°C for 18 hours. After separating the polystyrene sphere from the liquid and washing, it was stored at 4°C in PBS containing 01% bovine serum albumin and used.
(6)ペルオキシダーゼ標識抗体の調製(1)で得たH
OGの全分子構造に特異性の高いモノクローナル抗体5
ダと、西洋ワサビ由来のペルオキシダーゼ(シグマ社製
)5岬を公知の方法(Nakane P、 K、 an
d Kawaoi A : J、 Histocher
n cytochem。(6) Preparation of peroxidase-labeled antibody (1) H
Monoclonal antibody 5 highly specific for the entire molecular structure of OG
and horseradish-derived peroxidase (manufactured by Sigma) by a known method (Nakane P, K, an
d Kawai A: J, Histocher.
n cytochem.
22巻1084頁(1974年))により結合させセフ
ァデックスG−200で精製し、高活性画分をPBSで
1000倍に希釈して測定に供した。22, p. 1084 (1974)) and purified with Sephadex G-200, and the highly active fraction was diluted 1000 times with PBS and subjected to measurement.
(4)サンドインチ法
試験管にHOG標準液又は被検体を取り、PBSで20
0μlとする。次いで(2)で得たモノクローナル抗体
を不溶化したポリスチレン球を1個加え37℃で2時間
反応した後、PBSで2回洗浄した。(4) Take the HOG standard solution or test sample in a sandwich test tube and add PBS for 20 minutes.
Set the volume to 0 μl. Next, one polystyrene sphere in which the monoclonal antibody obtained in (2) was insolubilized was added and reacted at 37°C for 2 hours, followed by washing twice with PBS.
更[(3)で得タベルオキシダーゼ標識抗体を200μ
l加え37℃で2時間反応した。Further, add 200 μl of the Tabell oxidase-labeled antibody obtained in (3).
1 and reacted at 37°C for 2 hours.
PBSで2回洗浄後、02%の0−7二二レンジアミン
と001チの過酸化水素を含む基質溶液を1 ml加え
暗所で1時間反応後、1M−H2SO4溶液を3ml!
加えて反応を停止させた。反応液は4927L?FLの
吸光度を分光光度計により測定し、標準HOGの吸光度
により検量線を描き検体の吸光度をあて、。After washing twice with PBS, add 1 ml of a substrate solution containing 02% 0-7 22 diamine and 001 hydrogen peroxide, react for 1 hour in the dark, and then add 3 ml of 1M H2SO4 solution!
In addition, the reaction was stopped. Is the reaction solution 4927L? The absorbance of FL was measured using a spectrophotometer, a calibration curve was drawn using the absorbance of standard HOG, and the absorbance of the sample was applied.
はめて、HOG濃度を算出した。The HOG concentration was calculated.
測定結果を第1表に示した。The measurement results are shown in Table 1.
第1表 サンドイツチ法によるHOGの測定実施例2
LI(、FSHとの交叉反応測定検体としてHOG、
LH,FSHの標準液を用いて実施例1と同様にして
サンドインチ法テストを行なった。Table 1 Example 2 of measuring HOG using the Sand-Deutsch method
LI (, HOG as a sample for cross-reaction measurement with FSH,
A sandwich method test was conducted in the same manner as in Example 1 using standard solutions of LH and FSH.
測定結果を第1図に示した。The measurement results are shown in Figure 1.
LH,’FSHはI Q 007Lg/rnlの濃度で
も全く反応を示さなかった。LH,'FSH showed no reaction at all even at a concentration of IQ 007Lg/rnl.
発明の効果
本発明の試薬によるHOGの測定方法は、LHlPSH
と全く交叉反応を示さすHOGに極めて特異的な方法で
あり、産業上有用な方法である。Effects of the Invention The method for measuring HOG using the reagent of the present invention
This is an extremely specific method for HOG, which exhibits a complete cross-reaction with HOG, and is an industrially useful method.
図面は、本発明の試薬を用いる方法によるサンドインチ
法において、HOGとLH,FSHとの交叉反応を示し
た図である。
特許出願人 三井東圧化学株式会社
の ℃ マ
: 。 。 6 = −(mu乙
6シ) 面γ□遵6
手続補正書
昭和59年8月7日The drawing shows the cross-reaction of HOG with LH and FSH in the Sand Inch method using the reagent of the present invention. Patent applicant Mitsui Toatsu Chemical Co., Ltd. ℃ MA: . . 6 = - (mu Otsu 6shi) Men γ □ Jun 6 Procedural amendment August 7, 1982
Claims (1)
いモノクローナル抗体及びヒト絨毛性ゴナドトロピンの
βサブユニットに特異性の高いモノクローナル抗体を必
須成分とすることを特徴とするヒト絨毛性ゴナドトロピ
ンの測定試薬。A reagent for measuring human chorionic gonadotropin, which comprises as essential components a monoclonal antibody highly specific to the entire molecular structure of human chorionic gonadotropin and a monoclonal antibody highly specific to the β subunit of human chorionic gonadotropin.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13709284A JPS6117065A (en) | 1984-07-04 | 1984-07-04 | Measuring reagent for human chorionic gonadotropin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13709284A JPS6117065A (en) | 1984-07-04 | 1984-07-04 | Measuring reagent for human chorionic gonadotropin |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS6117065A true JPS6117065A (en) | 1986-01-25 |
Family
ID=15190690
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP13709284A Pending JPS6117065A (en) | 1984-07-04 | 1984-07-04 | Measuring reagent for human chorionic gonadotropin |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6117065A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01227060A (en) * | 1988-03-05 | 1989-09-11 | Tsunehiro Kitagawa | Immunoassay using antibody against immobilized antigen |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5228928A (en) * | 1975-08-30 | 1977-03-04 | Teikoku Hormone Mfg Co Ltd | Immunochemical reagent and process for its preparation |
JPS5695119A (en) * | 1979-10-29 | 1981-08-01 | University Patents Inc | Method and composition for detecting human cancer |
JPS5767858A (en) * | 1980-10-15 | 1982-04-24 | Takeda Chem Ind Ltd | Immunochemical measurement method for human chorionic gonadotropin and production of antibody |
JPS57201853A (en) * | 1981-06-08 | 1982-12-10 | Toyobo Co Ltd | Measuring method for human chorionic gonadotropin |
JPS5990054A (en) * | 1982-11-15 | 1984-05-24 | Takeda Chem Ind Ltd | Method and reagent for immunochemical mesurement of human chorionic gonadotropin |
-
1984
- 1984-07-04 JP JP13709284A patent/JPS6117065A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5228928A (en) * | 1975-08-30 | 1977-03-04 | Teikoku Hormone Mfg Co Ltd | Immunochemical reagent and process for its preparation |
JPS5695119A (en) * | 1979-10-29 | 1981-08-01 | University Patents Inc | Method and composition for detecting human cancer |
JPS5767858A (en) * | 1980-10-15 | 1982-04-24 | Takeda Chem Ind Ltd | Immunochemical measurement method for human chorionic gonadotropin and production of antibody |
JPS57201853A (en) * | 1981-06-08 | 1982-12-10 | Toyobo Co Ltd | Measuring method for human chorionic gonadotropin |
JPS5990054A (en) * | 1982-11-15 | 1984-05-24 | Takeda Chem Ind Ltd | Method and reagent for immunochemical mesurement of human chorionic gonadotropin |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01227060A (en) * | 1988-03-05 | 1989-09-11 | Tsunehiro Kitagawa | Immunoassay using antibody against immobilized antigen |
JPH0752194B2 (en) * | 1988-03-05 | 1995-06-05 | 常廣 北川 | Immunoassays using antibodies against solid antigens |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5262296A (en) | Freeze-dried composition containing enzyme-labeled anti-human interferon-β antibody and enzyme immunoassay kit containing the composition | |
US6391563B1 (en) | Method for the determination of antigens with the aid of three or more monoclonal antibodies | |
US4804626A (en) | Immunometric assay for the detection of human chorionic gonadotropin | |
JP2606722B2 (en) | Ultrasensitive antigenic substance measurement method | |
CN100445746C (en) | A method for detecting 19-nortestosterone and its special ELISA kit | |
GB2095831A (en) | Monoclonal antibody reagent and method for immunological assay | |
JPH06102037B2 (en) | Antibodies, manufacturing methods and applications | |
CN102876634B (en) | PMSG (pregnant mare serum gonadotropin) double-antibody sandwich ELISA (enzyme-linked immunosorbent assay) kit | |
EP0421392B1 (en) | Anti-hCG-beta core monoclonal antibody, its production and use | |
JP2736058B2 (en) | Manufacturing method of immunoassay device | |
EP0918218A2 (en) | Method for immunological assay | |
Bosch et al. | Characteristics of monoclonal antibodies against human chorionic gonadotrophin | |
JPS6117065A (en) | Measuring reagent for human chorionic gonadotropin | |
US4735898A (en) | Monoclonal antibodies and method of identifying species using the same | |
JP3018111B2 (en) | Assay method for monoclonal antibody and asialoglycoprotein receptor | |
JPH04108397A (en) | Monoclonal antibody and method for measuring tsh with the same | |
JPS5954966A (en) | Immunological measuring reagent | |
JPS62185169A (en) | Multipurpose immunochemical measuring method and reagent | |
JPS61218599A (en) | Determination of corpus luteum forming hormone, determinating reagent, monoclonal antibody therefor, obtaining method and hybridoma cell system | |
Fehskens et al. | Measurement of serum chorionic gonadotropin by a biotin-avidin labeled enzyme immunoassay | |
JP2657816B2 (en) | Immunoassay for erythropoietin | |
JPS6247554A (en) | Immunochemical measuring method of human epithelia cell growing factor and kit thereof | |
JPH03191863A (en) | Enzyme immunoassay method | |
Gupta et al. | Sandwich enzyme immunoassay of human chorionic gonadotropin using polystyrene beads as solid support | |
Mowers | Studies on the Binding of Human Chorionic Gonadotropin to Polystyrene & a Possible Application |